Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04697628
Title Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (innovaTV 301)
Recruitment Recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Seagen Inc.
Indications

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma

Therapies

Topotecan

Gemcitabine

Irinotecan

Tisotumab vedotin-tftv

Pemetrexed Disodium

Vinorelbine

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | CAN | BEL | AUT


No variant requirements are available.